Randolph, NJ, United States of America

Chi Li

This inventor holds 3 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chi Li. Retrieved from https://idiyas.com/inventor/chi-li-5twm3izl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chi Li

Introduction

Chi Li is a notable inventor based in Randolph, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 3 patents to his name, Chi Li has established himself as a key figure in his industry.

Latest Patents

Chi Li's latest patents include "Lactam inhibitors of factor Xa and method" and "Lactam inhibitors of FXa and method." These innovations are aimed at improving therapeutic options for patients requiring anticoagulation therapy. His work in this area demonstrates his commitment to advancing medical science and patient care.

Career Highlights

Chi Li is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role there allows him to leverage his expertise in drug development and contribute to groundbreaking research. His work has the potential to impact countless lives through improved treatment options.

Collaborations

Chi Li has collaborated with esteemed colleagues such as Philip D. Stein and Yan Shi. These partnerships highlight the importance of teamwork in the innovation process and the sharing of knowledge among experts in the field.

Conclusion

Chi Li's contributions to the pharmaceutical industry through his patents and collaborations underscore his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…